SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-13-044819
Filing Date
2013-08-12
Accepted
2013-08-12 17:27:39
Documents
2
Group Members
BAKER BROS. ADVISORS (GP) LLCFELIX J. BAKERJULIAN C. BAKER

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A v352386_sc13ga.htm SC 13G/A 99683
2 EXHIBIT 99.1 v352386_ex99-1.htm EX-99.1 5342
  Complete submission text file 0001144204-13-044819.txt   106764
Mailing Address 667 MADISON AVE 21ST FLOOR NEW YORK NY 10065
Business Address 667 MADISON AVE 21ST FLOOR NEW YORK NY 10065 2123395600
BAKER BROS. ADVISORS LP (Filed by) CIK: 0001263508 (see all company filings)

IRS No.: 134093645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Subject) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82196 | Film No.: 131030644
SIC: 2834 Pharmaceutical Preparations